Optimal loading dose of meropenem before continuous infusion in critically ill patients: a simulation study

Abstract The aim of this study was to investigate optimal loading doses prior to continuous infusion of meropenem in critically ill patients. A previously published and successfully evaluated pharmacokinetic model of critically ill patients was used for stochastic simulations of virtual patients. Ma...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Uwe Liebchen, Hanna Salletmeier, Simon Kallee, Christina Scharf, Lucas Huebner, Alexandra Weber, Michael Zoller
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/35be4501d4fa47959d11c96691e45305
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:35be4501d4fa47959d11c96691e45305
record_format dspace
spelling oai:doaj.org-article:35be4501d4fa47959d11c96691e453052021-12-02T16:34:53ZOptimal loading dose of meropenem before continuous infusion in critically ill patients: a simulation study10.1038/s41598-021-96744-32045-2322https://doaj.org/article/35be4501d4fa47959d11c96691e453052021-08-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-96744-3https://doaj.org/toc/2045-2322Abstract The aim of this study was to investigate optimal loading doses prior to continuous infusion of meropenem in critically ill patients. A previously published and successfully evaluated pharmacokinetic model of critically ill patients was used for stochastic simulations of virtual patients. Maintenance doses administered as continuous infusion of 1.5–6 g/24 h with preceding loading doses (administered as 30 min infusion) of 0.15–2 g were investigated. In addition to the examination of the influence of individual covariates, a best-case and worst-case scenario were simulated. Dosing regimens were considered adequate if the 5th percentile of the concentration–time profile did not drop at any time below four times the S/I breakpoint (= 2 mg/L) of Pseudomonas aeruginosa according to the EUCAST definition. Low albumin concentrations, high body weight and high creatinine clearances increased the required loading dose. A maximum loading dose of 0.33 g resulted in sufficient plasma concentrations when only one covariate showed extreme values. If all three covariates showed extreme values (= worst-case scenario), a loading dose of 0.5 g was necessary. Higher loading doses did not lead to further improvements of target attainment. We recommend the administration of a loading dose of 0.5 g meropenem over 30 min immediately followed by continuous infusion.Uwe LiebchenHanna SalletmeierSimon KalleeChristina ScharfLucas HuebnerAlexandra WeberMichael ZollerNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-6 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Uwe Liebchen
Hanna Salletmeier
Simon Kallee
Christina Scharf
Lucas Huebner
Alexandra Weber
Michael Zoller
Optimal loading dose of meropenem before continuous infusion in critically ill patients: a simulation study
description Abstract The aim of this study was to investigate optimal loading doses prior to continuous infusion of meropenem in critically ill patients. A previously published and successfully evaluated pharmacokinetic model of critically ill patients was used for stochastic simulations of virtual patients. Maintenance doses administered as continuous infusion of 1.5–6 g/24 h with preceding loading doses (administered as 30 min infusion) of 0.15–2 g were investigated. In addition to the examination of the influence of individual covariates, a best-case and worst-case scenario were simulated. Dosing regimens were considered adequate if the 5th percentile of the concentration–time profile did not drop at any time below four times the S/I breakpoint (= 2 mg/L) of Pseudomonas aeruginosa according to the EUCAST definition. Low albumin concentrations, high body weight and high creatinine clearances increased the required loading dose. A maximum loading dose of 0.33 g resulted in sufficient plasma concentrations when only one covariate showed extreme values. If all three covariates showed extreme values (= worst-case scenario), a loading dose of 0.5 g was necessary. Higher loading doses did not lead to further improvements of target attainment. We recommend the administration of a loading dose of 0.5 g meropenem over 30 min immediately followed by continuous infusion.
format article
author Uwe Liebchen
Hanna Salletmeier
Simon Kallee
Christina Scharf
Lucas Huebner
Alexandra Weber
Michael Zoller
author_facet Uwe Liebchen
Hanna Salletmeier
Simon Kallee
Christina Scharf
Lucas Huebner
Alexandra Weber
Michael Zoller
author_sort Uwe Liebchen
title Optimal loading dose of meropenem before continuous infusion in critically ill patients: a simulation study
title_short Optimal loading dose of meropenem before continuous infusion in critically ill patients: a simulation study
title_full Optimal loading dose of meropenem before continuous infusion in critically ill patients: a simulation study
title_fullStr Optimal loading dose of meropenem before continuous infusion in critically ill patients: a simulation study
title_full_unstemmed Optimal loading dose of meropenem before continuous infusion in critically ill patients: a simulation study
title_sort optimal loading dose of meropenem before continuous infusion in critically ill patients: a simulation study
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/35be4501d4fa47959d11c96691e45305
work_keys_str_mv AT uweliebchen optimalloadingdoseofmeropenembeforecontinuousinfusionincriticallyillpatientsasimulationstudy
AT hannasalletmeier optimalloadingdoseofmeropenembeforecontinuousinfusionincriticallyillpatientsasimulationstudy
AT simonkallee optimalloadingdoseofmeropenembeforecontinuousinfusionincriticallyillpatientsasimulationstudy
AT christinascharf optimalloadingdoseofmeropenembeforecontinuousinfusionincriticallyillpatientsasimulationstudy
AT lucashuebner optimalloadingdoseofmeropenembeforecontinuousinfusionincriticallyillpatientsasimulationstudy
AT alexandraweber optimalloadingdoseofmeropenembeforecontinuousinfusionincriticallyillpatientsasimulationstudy
AT michaelzoller optimalloadingdoseofmeropenembeforecontinuousinfusionincriticallyillpatientsasimulationstudy
_version_ 1718383744140705792